6533b7d2fe1ef96bd125f53b
RESEARCH PRODUCT
Additional file 1 of Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study
Marta Selma-royoChristine BäuerlDesirée Mena-tudelaLaia Aguilar-camprubíFrancisco J. Pérez-canoAnna Parra-llorcaCarles LerinCecilia Martínez-costaMaria Carmen Colladosubject
skin and connective tissue diseasesdescription
Additional file 1: Table S1. Reported maternal and infant side-effects after vaccination. Table S2. Results from the longitudinal mixed-effects analysis modeling the changes in IgG and IgA detection in human breast milk after vaccination. Figure S1. Individual trajectories of the SARS-CoV-2 IgG in breast milk samples according to vaccine from baseline (before the 1st dose) to 3-4 weeks post vaccination course (A-C) and grouped by vaccine (D-F). Data is presented as log-transformed arbitrary units (AU) and AU ± 95% CI. Figure S2. Individual trajectories of the SARS-CoV-2 IgA in breast milk samples according to vaccine from baseline transformed arbitrary units (AU) and AU ± 95% CI. Table S3. Percentage of mothers with a signal above the established cut-off for a positive result for SARS-CoV-2 antibody presence according to vaccine. Table S4. Results from the longitudinal mixed-effects analysis modeling the changes in IgG and IgA detection in human breast milk at baseline and each analyzed time after vaccination according to vaccine.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2022-01-01 |